Human Urinary PAH Tetraols
Chem. Res. Toxicol., Vol. 23, No. 5, 2010 907
C. E., Ed.) ACS Monograph 182, Vol. 1, pp 41-163, American
Chemical Society, Washington, DC.
(16) Harvey, R. G. (1991) Polycyclic Aromatic Hydrocarbons: Chemistry
and Carcinogenicity, Cambridge University Press, Cambridge, En-
gland.
(17) Geacintov, N. E., Cosman, M., Hingerty, B. E., Amin, S., Broyde, S.,
and Patel, D. J. (1997) NMR solution structures of stereoisomeric
covalent polycyclic aromatic carcinogen-DNA adducts: Principles,
patterns, and diversity. Chem. Res. Toxicol. 10, 112–146.
(18) Szeliga, J., and Dipple, A. (1998) DNA adduct formation by polycyclic
aromatic hydrocarbon dihydrodiol epoxides. Chem. Res. Toxicol. 11,
1–11.
(19) Welch, R. M., Harrison, Y. E., Conney, A. H., Poppers, P. J., and
Finster, M. (1968) Cigarette smoking: Stimulatory effect on metabo-
lism of 3,4-benzpyrene by enzymes in human placenta. Science 160,
541–542.
(20) Kellermann, G., Shaw, C. R., and Luyten-Kellerman, M. (1973) Aryl
hydrocarbon hydroxylase inducibility and bronchogenic carcinoma.
N. Engl. J Med. 289, 934–937.
(21) Harris, C. C., Autrup, H., Connor, R., Barrett, L. A., McDowell, E. M.,
and Trump, B. F. (1976) Interindividual variation in binding of
benzo[a]pyrene to DNA in cultured human bronchi. Science 194,
1067–1069.
(33) Veglia, F., Matullo, G., and Vineis, P. (2003) Bulky DNA adducts
and risk of cancer: A meta-analysis. Cancer Epidemiol. Biomarkers
PreV. 12, 157–160.
(34) Raimondi, S., Paracchini, V., Autrup, H., Barros-Dios, J. M., Ben-
hamou, S., Boffetta, P., Cote, M. L., Dialyna, I. A., Dolzan, V.,
Filiberti, R., Garte, S., Hirvonen, A., Husgafvel-Pursiainen, K.,
Imyanitov, E. N., Kalina, I., Kang, D., Kiyohara, C., Kohno, T.,
Kremers, P., Lan, Q., London, S., Povey, A. C., Rannug, A., Reszka,
E., Risch, A., Romkes, M., Schneider, J., Seow, A., Shields, P. G.,
Sobti, R. C., Sorensen, M., Spinola, M., Spitz, M. R., Strange, R. C.,
Stucker, I., Sugimura, H., To-Figueras, J., Tokudome, S., Yang, P.,
Yuan, J. M., Warholm, M., and Taioli, E. (2006) Meta- and pooled
analysis of GSTT1 and lung cancer: A HuGE-GSEC review. Am. J.
Epidemiol. 164, 1027–1042.
(35) Carlsten, C., Sagoo, G. S., Frodsham, A. J., Burke, W., and Higgins,
J. P. (2008) Glutathione S-transferase M1 (GSTM1) polymorphisms
and lung cancer: A literature-based systematic HuGE review and meta-
analysis. Am. J. Epidemiol. 167, 759–774.
(36) Hecht, S. S., Chen, M., Yagi, H., Jerina, D. M., and Carmella, S. G.
(2003) r-1 t-2,3,c-4-Tetrahydroxy-1,2,3,4-tetrahydrophenanthrene in
human urine: a potential biomarker for assessing polycyclic aromatic
hydrocarbon metabolic activation. Cancer Epidemiol. Biomarkers PreV.
12, 1501–1508.
(22) Sabadie, N., Richter-Reichhelm, H. B., Saracci, R., Mohr, U., and
Bartsch, H. (1981) Inter-individual differences in oxidative ben-
zo(a)pyrene metabolism by normal and tumorous surgical lung
specimens from 105 lung cancer patients. Int. J. Cancer 27, 417–
425.
(23) Nowak, D., Schmidt-Preuss, U., Jorres, R., Liebke, F., and Rudiger,
H. W. (1988) Formation of DNA adducts and water-soluble metabo-
lites of benzo[a]pyrene in human monocytes is genetically controlled.
Int. J. Cancer 41, 169–173.
(24) McLemore, T. L., Adelberg, S., Liu, M. C., McMahon, N. A., Yu,
S. J., Hubbard, W. C., Czerwinski, M., Wood, T. G., Storeng, R.,
Lubet, R. A., Eggleston, J. C., Boyd, M. R., and Hines, R. N. (1990)
Expression of CYP1A1 gene in patients with lung cancer: Evidence
for cigarette smoke-induced gene expression in normal lung tissue
and for altered gene regulation in primary pulmonary carcinomas.
J. Natl. Cancer Inst. 82, 1333–1339.
(25) Kiyohara, C., Nakanishi, Y., Inutsuka, S., Takayama, K., Hara, N.,
Motohiro, A., Tanaka, K., Kono, S., and Hirohata, T. (1998) The
relationship between CYP1A1 aryl hydrocarbon hydroxylase activity
and lung cancer in a Japanese population. Pharmacogenetics 8, 315–
323.
(26) Nebert, D. W. (2000) Drug-metabolizing enzymes, polymorphisms
and interindividual response to environmental toxicants. Clin. Chem.
Lab. Med. 38, 857–861.
(27) Alexandrov, K., Cascorbi, I., Rojas, M., Bouvier, G., Kriek, E., and
Bartsch, H. (2002) CYP1A1 and GSTM1 genotypes affect ben-
zo[a]pyrene DNA adducts in smokers’ lung: Comparison with
aromatic/hydrophobic adduct formation. Carcinogenesis 23, 1969–
1977.
(28) Bartsch, H., Nair, U., Risch, A., Rojas, M., Wikman, H., and
Alexandrov, K. (2000) Genetic polymorphism of CYP genes, alone
or in combination, as a risk modifier of tobacco-related cancers. Cancer
Epidemiol. Biomarkers PreV. 9, 3–28.
(29) Smith, G. B., Harper, P. A., Wong, J. M., Lam, M. S., Reid, K. R.,
Petsikas, D., and Massey, T. E. (2001) Human lung microsomal
cytochrome P4501A1 (CYP1A1) activities: impact of smoking status
and CYP1A1, aryl hydrocarbon receptor, and glutathione S- transferase
M1 genetic polymorphisms. Cancer Epidemiol. Biomarkers PreV. 10,
839–853.
(30) Lee, W. J., Brennan, P., Boffetta, P., London, S. J., Benhamou, S.,
Rannug, A., To-Figueras, J., Ingelman-Sundberg, M., Shields, P.,
Gaspari, L., and Taioli, E. (2002) Microsomal epoxide hydrolase
polymorphisms and lung cancer risk: A quantitative review. Biomar-
kers 7, 230–241.
(31) Benhamou, S., Lee, W. J., Alexandrie, A. K., Boffetta, P., Bouchardy,
C., Butkiewicz, D., Brockmoller, J., Clapper, M. L., Daly, A., Dolzan,
V., Ford, J., Gaspari, L., Haugen, A., Hirvonen, A., Husgafvel-
Pursiainen, K., Ingelman-Sundberg, M., Kalina, I., Kihara, M.,
Kremers, P., Le Marchand, L., London, S. J., Nazar-Stewart, V., Onon-
Kihara, M., Rannug, A., Romkes, M., Ryberg, D., Seidegard, J.,
Shields, P., Strange, R. C., Stucker, I., To-Figueras, J., Brennan, P.,
and Taioli, E. (2002) Meta- and pooled analyses of the effects of
glutathione S-transferase M1 polymorphisms and smoking on lung
cancer risk. Carcinogenesis 23, 1343–1350.
(32) Hung, R. J., Boffetta, P., Brockmoller, J., Butkiewicz, D., Cascorbi,
I., Clapper, M. L., Garte, S., Haugen, A., Hirvonen, A., Anttila, S.,
Kalina, I., Le Marchand, L., London, S. J., Rannug, A., Romkes, M.,
Salagovic, J., Schoket, B., Gaspari, L., and Taioli, E. (2003) CYP1A1
and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian
non-smokers: A pooled analysis. Carcinogenesis 24, 875–882.
(37) Shou, M., Korzekwa, K. R., Krausz, K. W., Crespi, C. L., Gonzalez,
F. J., and Gelboin, H. V. (1994) Regio- and stereo-selective metabolism
of phenanthrene by twelve cDNA-expressed human, rodent, and rabbit
cytochromes P-450. Cancer Lett. 83, 305–313.
(38) Hecht, S. S., Chen, M., Yoder, A., Jensen, J., Hatsukami, D., Le, C.,
and Carmella, S. G. (2005) Longitudinal study of urinary phenanthrene
metabolite ratios: Effect of smoking on the diol epoxide pathway.
Cancer Epidemiol. Biomarkers PreV. 14, 2969–2974.
(39) Hecht, S. S., Carmella, S. G., Yoder, A., Chen, M., Li, Z., Le, C.,
Jensen, J., and Hatsukami, D. K. (2006) Comparison of polymorphisms
in genes involved in polycyclic aromatic hydrocarbon metabolism with
urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol.
Biomarkers PreV. 15, 1805–1811.
(40) Nordqvist, M., Thakker, D. R., Vyas, K. P., Yagi, H., Levin, W., Ryan,
D. E., Thomas, P. E., Conney, A. H., and Jerina, D. M. (1981)
Metabolism of chrysene and phenanthrene to bay-region diol epoxides
by rat liver enzymes. Mol. Pharmacol. 19, 168–178.
(41) Hecht, S. S., Berg, J. Z., and Hochalter, J. B. (2009) Preferential
glutathione conjugation of a reverse diol epoxide compared to a bay
region diol epoxide of phenanthrene in human hepatocytes: Relevance
to molecular epidemiology studies of glutathione-S-transferase poly-
morphisms and cancer. Chem. Res. Toxicol. 22, 426–432.
(42) Simpson, C. D., Wu, M. T., Christiani, D. C., Santella, R. M., Carmella,
S. G., and Hecht, S. S. (2000) Determination of r-7,t-8,9,c-10-
tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine by gas
chromatography-negative ion chemical ionization-mass spectrometry.
Chem. Res. Toxicol. 13, 271–280.
(43) Weston, A., Bowman, E. D., Carr, P., Rothman, N., and Strickland,
P. T. (1993) Detection of metabolites of polycyclic aromatic hydro-
carbons in human urine. Carcinogenesis 14, 1053–1055.
(44) Boysen, G., and Hecht, S. S. (2003) Analysis of DNA and protein
adducts of benzo[a]pyrene in human tissues using structure-specific
methods. Mutat. Res. 543, 17–30.
(45) Ragin, A. D., Crawford, K. E., Etheredge, A. A., Grainger, J., and
Patterson, D. G., Jr. (2008) A gas chromatography-isotope dilution
high-resolution mass spectrometry method for quantification of
isomeric benzo[a]pyrene diol epoxide hemoglobin adducts in humans.
J. Anal. Toxicol. 39, 728–736.
(46) Beland, F. A., Churchwell, M. I., Von Tungeln, L. S., Chen, S., Fu,
P. P., Culp, S. J., Schoket, B., Gyorffy, E., Minarovits, J., Poirier,
M. C., Bowman, E. D., Weston, A., and Doerge, D. R. (2005) High-
performance liquid chromatography electrospray ionization tandem
mass spectrometry for the detection and quantitation of benzo[a]pyr-
ene-DNA adducts. Chem. Res. Toxicol. 18, 1306–1315.
(47) Hecht, S. S., Villalta, P. W., and Hochalter, J. B. (2008) Analysis of
phenanthrene diol epoxide mercapturic acid detoxification products
in human urine: Relevance to molecular epidemiology studies of
glutathione-S-transferase polymorphisms. Carcinogenesis 29, 937–943.
(48) Whalen, D. L., Ross, A. M., Yagi, H., Karle, J. M., and Jerina, D. M.
(1978) Stereoelectronic factors in the solvolysis of bay region diol
epoxides of polycyclic aromatic hydrocarbons. J. Am. Chem. Soc. 100,
5218–5221.
(49) Weems, H. B., and Yang, S. K. (1989) Chiral stationary phase high-
performance liquid chromatographic resolution and absolute config-
uration of enantiomeric benzo[a]pyrene diol-epoxides and tetrols.
Chirality 1, 276–283.
(50) Jiang, H., Shen, Y. M., Quinn, A. M., and Penning, T. M. (2005)
Competing roles of cytochrome P450 1A1/1B1 and aldo-keto reductase
1A1 in the metabolic activation of (()-7,8-dihydroxy-7,8-dihydro-